Predictions
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.40
04.11.20
04.11.20
-
-9.38%
07.11.20
07.11.20
Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.46
03.11.20
03.11.20
€3.50
04.11.21
04.11.21
-4.88%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.45
03.11.20
03.11.20
-
04.11.21
04.11.21
136.51%
15.01.21
15.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.53
03.11.20
03.11.20
€10.50
04.11.21
04.11.21
51.47%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.15
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
-4.96%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.20
02.11.20
02.11.20
€5.00
02.11.20
02.11.20
-0.74%
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.08
02.11.20
02.11.20
-
04.11.21
04.11.21
-25.32%
07.11.20
07.11.20
Probably not worthwhile Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€49.75
31.10.20
31.10.20
-
04.11.21
04.11.21
0.53%
09.11.20
09.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.36
30.10.20
30.10.20
€2.00
31.10.20
31.10.20
-25.00%
31.10.20
31.10.20
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.45
29.10.20
29.10.20
-
04.11.21
04.11.21
-0.78%
04.11.20
04.11.20
Could be very worthwhile Investment >20% year
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€8.64
28.10.20
28.10.20
-
04.11.21
04.11.21
31.94%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€65.91
28.10.20
28.10.20
-
04.11.21
04.11.21
-7.22%
13.11.20
13.11.20
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€267.50
27.10.20
27.10.20
€300.00
31.10.20
31.10.20
8.41%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
27.10.20
27.10.20
-
04.11.21
04.11.21
-24.99%
15.07.21
15.07.21
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.50
27.10.20
27.10.20
-
29.10.20
29.10.20
-0.77%
29.10.20
29.10.20
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€65.45
26.10.20
26.10.20
-
28.10.20
28.10.20
0.70%
28.10.20
28.10.20
Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.60
26.10.20
26.10.20
-
27.10.20
27.10.20
-1.52%
27.10.20
27.10.20
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
26.10.20
26.10.20
-
27.10.20
27.10.20
0.00%
27.10.20
27.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€8.95
26.10.20
26.10.20
-
26.10.20
26.10.20
-0.56%
26.10.20
26.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€9.25
26.10.20
26.10.20
-
26.10.20
26.10.20
-3.24%
26.10.20
26.10.20
Risky Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.03
24.10.20
24.10.20
€58.00
04.11.21
04.11.21
-0.20%
11.11.20
11.11.20
Medium risks for its business
Risky Investment
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€2.10
23.10.20
23.10.20
€1.00
04.11.21
04.11.21
7.62%
04.11.20
04.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies